Clinical Study
Early Real-World Experience with CoreValve Evolut PRO and R Systems for Transcatheter Aortic Valve Replacement
Table 3
Device success at discharge.
| | Evolut PRO (N = 60) | Evolut R (N = 56) | value |
| Absence of procedural mortality | 60 (100) | 56 (100) | 1.00 | Correct positioning of single valve in proper anatomical location | 60 (100) | 56 (100) | 1.00 | Intended performance of prosthetic heart valve | | | | No prosthesis-patient mismatch | 60 (100) | 56 (100) | 1.00 | Mean gradient <20 mm Hg or peak velocity <3 m/s | 60 (100) | 55 (98) | 0.79 | Absence of moderate or severe prosthetic regurgitation | 57 (95) | 50 (89) | 0.25 | Overall device success | 54 (90.0) | 50 (89.3) | 0.90 |
|
|
Values are n (%).
|